Tissue Regenix significantly undervalued against peers (VIDEO)

Tissue Regenix Group plc (LON:TRX) is the topic of conversation when Dr Martin Hall joins DirectorsTalk Interviews.

Martin reminds us of what the company does, summerises the key details from its trading update, talks though the implications of a strong sales performance, the key value added in the reserach report and thoughts on what will happen to the share price.

Tissue Regenix Group is a pioneering, international medical technology company, focusing on the development of regenerative products.

You might also enjoy reading  Surface Transforms its all in the detail (VIDEO)
Find more news, interviews, share price & company profile here for:
Hardman & Co

Share this interview

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp
Tissue Regenix significantly undervalued against peers (VIDEO)

Other Interviews

More News

Ask your questions

Do you have questions you’d like to ask this company, get in touch and we’ll ask them for you.   

I have questions